Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Frontiers in Immunology
|
August 11, 2025
Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study
Sara Massironi, Giulia Dispinzieri, Alberto Rossi, et al.
The American Journal of Pathology
|
July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
Chiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology
|
March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Frontiers in Immunology
|
August 11, 2025
Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study
Sara Massironi, Giulia Dispinzieri, Alberto Rossi, et al.
The American Journal of Pathology
|
July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
Chiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology
|
March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Page
of 4